Paracrine provision of lipids in the immune system

Current Immunology Reviews

Volumn 5, Issue 2, 2009, Pages 150-160

  Pond, Caroline M ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

Adipose tissue; Crohn's disease; Dendritic cells; HIV associated adipose redistribution syndrome; Lymph nodes; Nutrition; Perinodal adipocytes

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LIPID; OMEGA 3 FATTY ACID; PALMITIC ACID; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VERY LONG CHAIN FATTY ACID;

ADIPOCYTE; ADIPOSE TISSUE; BODY FAT DISTRIBUTION; CROHN DISEASE; DENDRITIC CELL; FATTY ACID DESATURATION; HIV ASSOCIATED LIPODYSTROPHY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTROPHY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; LIPID COMPOSITION; LIPOLYSIS; LYMPH NODE; LYMPHOID CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; VIRUS LOAD;

EID: 68549137927     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339509788166958     Document Type: Review

References (177)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-9.
2. Balazy M. Eicosanomics: targeted lipidomics of eicosanoids in biological systems. Prostagland Lipid Mediat 2004; 73: 173-80.
3. De Libero G, Mori L. Mechanisms of lipid-antigen generation and presentation to T cells. Trends Immunol 2006; 27: 485-92.
4. Mori L, De Libero G. Presentation of lipid antigens to T cells. Immunol Letts 2008; 117: 1-8.
5. Boyce JA. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev 2007; 217: 168-85.
6. Pizzo P, Viola A. Lipid-based membrane microdomains in T cell activation. Curr Immunol Rev 2005; 1: 7-12.
7. Calder PC, Yaqoob P. Lipid rafts - Composition, characterization, and controversies. J Nutr 2007; 137: 545-7.
8. Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008; 47: 147-55.
9. Bozza PT, Melo RCN, Bandeira-Melo C. Leukocyte lipid bodies regulation and function: Contribution to allergy and host defense. Pharmacol Therapeut 2007; 113: 30-49.
10. Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers. Curr Topics Medic Chem 2007; 7: 311-40.
11. Stulnig TM, Zeyda M. Immunomodulation by polyunsaturated fatty acids: Impact on T-cell signaling. Lipids 2004; 39: 1171-5.
12. Calder PC. Immunomodulation by omega-3 fatty acids. Prostagland Leukot Essent Fatty Acids 2007; 77: 327-35.
13. Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Ann Rev Pathol-Mech Dis 2008; 3: 279-312.
14. Zeyda M, Stulnig TM. Lipid Rafts & Co.: An integrated model of membrane organization in T cell activation. Prog Lipid Res 2006; 45: 187-202.
15. Geyeregger R, Zeyda M, Zlabinger GJ, Waldhausl W, Stulnig TM. Polyunsaturated fatty acids interfere with formation of the immunological synapse. J Leukoc Biol 2005; 77: 680-8.
16. Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 2005; 174: 5390-7.
17. De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, Mongrand S, Laye S. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J Neurochem 2008; 105: 296-307.
18. Önfelt B, Nedvetzki S, Yanagi K, Davis DM. Cutting edge: Membrane nanotubes connect immune cells. J Immunol 2004; 173: 1511-3.
19. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003; 44: 479-86.
20. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004; 41: 41-78.
21. Wheatley KE, Nichols PD, Hindell MA, Harcourt RG, Bradshaw CJA. Differential mobilization of blubber fatty acids in lactating weddell seals: Evidence for selective use. Physiol Biochem Zool 2008; 81: 651-62.
22. McCue MD. Western diamondback rattlesnakes demonstrate physiological and biochemical strategies for tolerating prolonged starvation. Physiol Biochem Zool 2007; 80: 25-34.
23. Pond CM. Paracrine interactions of mammalian adipose tissue. J Exp Zool 2003; 295A: 99-110.
24. Heath T, Brandon R. Lymphatic and blood vessels of the popliteal node in sheep. Anat Rec 1983; 207: 461-72.
25. Pond CM. Paracrine relationships between adipose and lymphoid tissues: implications for the mechanism of HIV-associated adipose redistribution syndrome. Trends Immunol 2003; 24: 13-8.
26. Harvey NL. The link between lymphatic function and adipose biology. Annals NY Acad Sci 2008; 1131: 82-8.
27. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-808.
28. Khazen W, M'Bika JP, Tomkiewiez C, et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Letts 2005; 579: 5631-4.
29. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G, Zlabinger GJ, Stulnig TM. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive proinflammatory mediator production. Int J Obesity 2007; 31: 1420-8.
30. Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008; 118: 2640-50.
31. Nishimura S, Manabe I, Nagasaki M, et al. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 2008; 118: 710-21.
32. Mills SC, Windsor AC, Knight SC. The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin Exp Immunol 2005; 142: 216-28.
33. Mattacks CA, Sadler D, Pond CM. The effects of dietary lipids on dendritic cells in perinodal adipose tissue during chronic mild inflammation. Brit J Nutr 2004; 91: 883-91.
34. Pond CM. Adipose tissue and the immune system. Prostagland Leukot Essent Fatty Acids 2005; 73: 17-30.
35. Mattacks CA, Sadler D, Pond CM. The control of lipolysis in perinodal and other adipocytes by lymph node and adipose tissue-derived dendritic cells in rats. Adipocytes 2005; 1: 43-56.
36. Mattacks CA, Sadler D, Pond CM. Site-specific differences in the fatty acid compositions of dendritic cells and associated adipose tissue in popliteal depot, mesentery and omentum, and their modulation by chronic inflammation and dietary lipids. Lymph Res Biol 2004; 2: 107-29.
37. Mattacks CA, Pond CM. The effects of feeding suet-enriched chow on site-specific differences in the composition of triacylglycerol fatty acids in adipose tissue and its interactions in vitro with lymphoid cells. Brit J Nutr 1997; 77: 621-43.
38. Gehring S, Gregory SH, Wintermeyer P, Martin MS, Aloman C, Wands JR. Generation and characterization of an immunogenic dendritic cell population. J Immunol Meth 2008; 332: 18-30.
39. Ivanova PT, SB Milne, JS Forrester, HA Brown. Lipid arrays: New tools in the understanding of membrane dynamics and lipid signaling. Mol Interv 2004; 4: 86-96.
40. Quehenberger O, Armando A, Dumlao D, Stephens DL, Dennis EA. Lipidomics analysis of essential fatty acids in macrophages. Prostagland Leukot Essent Fatty Acids 2008; 79: 123-9.
41. Enke U, Seyfarth L, Schleussner E, Markert UR. Impact of PUFA on early immune and fetal development. Brit J Nutr 2008; 100: 1158-68.
42. Raclot T. Selective mobilization of fatty acids from adipose tissue triacylglycerols. Prog Lipid Res 2003; 42: 257-88.
43. Guschina IA, Harwood JL. Mechanisms of temperature adaptation in poikilotherms. FEBS Letts 2006; 580: 5477-83.
44. Pond CM, Mattacks CA. The source of fatty acids incorporated into proliferating lymphoid cells in immune-stimulated lymph nodes. Brit J Nutr 2003; 89: 375-82.
45. Pond CM, Mattacks CA. In vivo evidence for the involvement of the adipose tissue surrounding lymph nodes in immune responses. Immunol Letts 1998; 63: 159-67.
46. Pond CM, Mattacks CA. The activation of adipose tissue associated with lymph nodes during the early stages of an immune response. Cytokine 2002; 17: 131-9.
47. MacQueen HA, Pond CM. Immunofluorescent localisation of tumour necrosis factor-α receptors on the popliteal lymph node and the surrounding adipose tissue following a simulated immune challenge. J Anat, Lond 1998; 192: 223-31.
48. Mattacks CA, Pond CM. Interactions of noradrenalin and tumour necrosis factor-α, interleukin-4 and interleukin-6 in the control of lipolysis from adipocytes around lymph nodes. Cytokine 1999; 11: 334-46.
49. Sadler D, Mattacks CA, Pond CM. Changes in adipocytes and dendritic cells in lymph node-containing adipose depots during and after many weeks of mild inflammation. J Anat Lond 2005; 207: 761-89.
50. Calabro P, Yeh ETH. Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk. Curr Hypertens Rep 2008; 10: 32-8.
51. Harvey NL, Srinivasan RS, Dillard ME, et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nature Genet 2005; 37: 1072-81.
52. Backhed F, Crawford PA, O'Donnell D, Gordon JI. Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc Natl Acad Sci USA 2007; 104: 606-11.
53. Johnson RW. The concept of sickness behavior: a brief chronological account of four key discoveries. Vet Immunol Immunopathol 2002; 87: 443-50.
54. Pond CM. Interactions of adipose and lymphoid tissues. In "Nutrition and Health: Adipose tissue and Adipokines in Health and Disease" (GFaT Mazzone, ed.),2007. pp. 133-50. Humana Press Inc., Totowa N.J.
55. Gyllensten L. The postnatal histogenesis of the lymphatic system of guinea-pigs. Acta Anat 1950; 10: 130-60.
56. Pond CM. Interactions between adipose tissue and the immune system. Proc Nutr Soc 1996; 55: 111-26.
57. Cousin B, Munoz O, André M, et al. A role for preadipocytes as macrophage-like cells. FASEB J 1999; 13: 305-31.
58. Cousin B, André M, Casteilla L, Pénicaud L. Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cellul Physiol 2001; 186: 380-6.
59. Charrière G, Cousin B, Arnaud E, André M, Bacou F, Pénicaud L, Casteilla L. Preadipocyte conversion to macrophage - Evidence of plasticity. J Biol Chem 2003; 278: 9850-5.
60. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000; 275: 24255-63.
61. Ajuwon KM, Jacobi SK, Kuske JL, Spurlock ME. Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-gamma in primary pig adipocytes. Am J Physiol-Regul Integr Comp Physiol 2004; 286: R547-R53.
62. Villena JA, Cousin B, Pénicaud L, Casteilla L. Adipose tissues display differential phagocytic and microbicidal activities depending on their localization. Int J Obes 2001; 25: 1275-80.
63. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes - Role of free fatty acids and tumor necrosis factor alpha. Arterioscl Thromb Vasc Biol 2005; 25: 2062-8.
64. Saillan-Barreau C, Cousin B, André M, Villena P, Casteilla L, Pénicaud L. Human adipose cells as candidates in defense and tissue remodeling phenomena. Biochem Biophys Res Commun 2003; 309: 502-5.
65. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 2005; 8: 347-54.
66. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue - A culprit underlying the metabolic syndrome and atherosclerosis. Arteriosclerosis Thromb VascBiol 2007; 27: 2276-83.
67. Zeyda M, Stulnig TM. Adipose tissue macrophages. Immunol Letts 2007; 112: 61-7.
68. Knight SC. Specialized perinodal fat fuels and fashions immunity. Immunity 2008; 28: 135-8.
69. Schäffler A, Müller-Ladner U, Schölmerich J, Büchler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 2006; 27: 449-67.
70. Stulnig TM. Immunomodulation by polyunsaturated fatty acids: Mechanisms and effects. Int Arch Allergy Immunol 2003; 132: 310-21.
71. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61: 345-58.
72. Striker R, Conlin D, Marx M, Wiviott L. Localized adipose tissue hypertrophy in patients receiving human immunodeficiency virus protease inhibitors. Clin Infect Dis 1998; 27: 218-20.
73. Tien PC, Grunfeld C. What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis 2004; 17: 27-32.
74. Shaw AJ, McLean, Evans BA. Disorders of fat distribution in HIV infection. Int J STD AIDS 1998; 9: 595-9.
75. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-F8
76. Saint-Marc T, Partisani M, Poizot-Martin I, et al. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving longterm nucleoside analogue therapy. AIDS 1999; 13: 1659-67.
77. Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003; 361: 726-35.
78. John M, Nolan D, Mallal S. Antiretroviral therapy and the lipodystrophy syndrome. Antivir Therap 2001; 6: 9-20.
79. Madge S, Kinloch-de-Loes S, Mercey D, Johnson MA, IVD Weller. Lipodystrophy in patients naive to HIV protease inhibitors. AIDS 1999; 13: 735-7.
80. Leonard EG, McComsey GA. Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J 2003; 22: 77-84.
81. Iacobellis G, AM Pellicelli, Sharma AM, Grisorio B, Barbarini G, Barbaro G. Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol 2007; 99: 1470-2.
82. Blanco JL, Biglia A, Martinez E, et al. Intrathoracic fat in HIV-infected patients. HIV Med 2006; 7: 213-7.
83. Guallar JP, Gallego-Escuredo JM, Domingo JC, et al. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy. AIDS 2008; 22: 575-84.
84. Hruz PW, Murata H, Mueckler M. Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism. Am J Physiol 2001; 280: E549-E53.
85. Mattacks CA, Sadler D, Pond CM. Site-specific differences in the action of NRTI drugs on adipose tissue incubated in vitro with lymphoid cells, and their interaction with dietary lipids. Comp Biochem Physiol 2003; 135C: 11-29.
86. Mattacks CA, Sadler D, Pond CM. The cellular structure and lipid/protein composition of adipose tissue surrounding chronically stimulated lymph nodes in rats. J Anat Lond 2003; 202: 551-61.
87. O'Neil SP, Mossman SP, Maul DH, Hoover EA. In vivo cell and tissue tropism of SIVsmmPBj14-bcl.3. AIDS Res Hum Retrovir 1999; 15: 203-15.
88. Lopez MC, Huang DS, Watson RR. Changes in mesenteric lymph node T cell phenotype and B and T cell homing properties after murine AIDS infection. Lymphology 2002; 35: 76-86.
89. Li QS, Duan LJ, Estes JD, et al. Peak SIV replication in resting memory CD4(+) T cells depletes gut lamina propria CD4(+) T cells. Nat Med 2005; 434: 1148-52.
90. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-71.
91. Chen DL, Misra A, Garg A. Lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2002; 87: 4845-56.
92. Brambilla P, Bricalli D, Sala N, et al. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS 2001; 15: 2415-22.
93. Vigano A, Mora S, Testolin C, et al. Increased lipodystrophy is associated with increased exposure to highly active Antiretroviral therapy in HIV-infected children. J AIDS 2003; 32: 482-9.
94. Galli M, Cozzi-Lepri A, Ridolfo AL, et al. Incidence of adipose tissue alterations in first-line antiretroviral therapy - The LipoI-CoNa study. Arch Intern Med 2002; 162: 2621-8.
95. Galli M, Gervasoni C, Ridolfo AL, et al. Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting. AIDS 2003; 17 Suppl 1: S155-61.
96. Path G, Bornstein SR, Gurniak M, Chrousos GP, Scherbaum WA, Hauner H. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: Increased IL-6 production by β-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab 2001; 86: 2281-8.
97. Bandyopadhyay GK, Lee LY, Guzman RC, Nandi S. Effect of reproductive states on lipid mobilization and linoleic acid metabolism in mammary glands. Lipids 1995; 30: 155-62.
98. Raclot T, Langin D, Lafontan M, Groscolas R. Selective release of human adipocyte fatty acids according to molecular structure. Biochem J 1997; 324: 911-5.
99. Dong KL, Bausserman LL, Flynn MM, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J AIDS 1999; 21: 107-13.
100. Gervasoni C, Ridolfo AL, Trifirò G, et al. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 1999; 13: 465-71.
101. Evans DL, Pantanowitz L, Dezube BJ, Aboulafia DM. Breast enlargement in 13 men who were seropositive for human immunodeficiency virus. Clin Infect Dis 2002; 35: 1113-9.
102. Gervasoni C, Ridolfo AL, Rovati L, Vaccarezza M, Cassana L, Galli M. Maintenance of breast size reduction after mastoplasty and switch to a protease inhibitor-sparing regimen in an HIV- positive woman with highly active antiretroviral therapy- associated massive breast enlargement. AIDS Patient Care STDS 2002; 16: 307-11.
103. Kahn JL, Wolfram-Gabel R, Bourjat P. Anatomy and imaging of the deep fat of the face. Clin Anat 2000; 13: 373-82.
104. Fogt F, Zimmerman RL, Daly T, Gausas RE. Observation of lymphatic vessels in orbital fat of patients with inflammatory conditions: A form fruste of lymphangiogenesis? Int J Mol Med 2004; 13: 681-3.
105. Heufelder AE. Interactions of fibroblasts, adipocytes and immunocompetent cells in the pathogenesis of Graves' ophthalmopathy. Acta Med Austr 2001; 28: 89-92.
106. Schrauwen P. High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc Lond 2007; 66: 33-41.
107. Villarroya F, Domingo P, Giralt M. Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity. Trends Pharmacol Sci 2005; 26: 88-93.
108. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis, a pathologic and clinical entity. J Am Med Assoc 1932; 99: 1323-9.
109. Sheehan AL, BF Warren, MWL Gear, NA Shepherd. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Brit J Surg 1992; 79: 955-8.
110. McGowan IM, Fairhurst RM, Shanahan F, Anton PA. Mucosal substance P receptor expression in HIV infection and inflammatory bowel disease. Neuroimmunomodulation 1997; 4: 70-6.
111. Lautenbach E, Lichtenstein GR. Human immunodeficiency virus infection and Crohn's disease: The role of the CD4 cell in inflammatory bowel disease. J Clin Gastroent 1997; 25: 456-9.
112. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999; 117: 73-81.
113. Schäffler A, Herfarth H. Creeping fat in Crohn's disease: traveling in a creeper lane of research? Gut 2005; 54: 742-4.
114. Middel P, Raddatz D, Gunawan B, Haller F, Radzun HJ. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 2006; 55: 220-7.
115. Schäffler A, Schölmerich J, Büchler C. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab 2007; 3: 345-54.
116. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, et al. Mesenteric fat in Crohn's disease: A pathogenetic hallmark or an innocent bystander? Gut 2007; 56: 577-83.
117. Pond CM. The contribution of wild animal biology to human physiology and medicine. Écoscience 2003; 10: 1-9.
118. Westcott EDA, Windsor ACJ, Mattacks CA, Pond CM, Knight SC. Fatty acid compositions of lipids in mesenteric adipose tissue and lymphoid cells in patients with and without Crohn's disease and their therapeutic implications. Inflamm Bowel Dis 2005; 11: 820-7.
119. Trebble TM, Arden NK, Wootton SA, et al. Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease. Clin Nutr 2004; 23: 647-55.
120. Harizi H, Gualde N. Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 459-66.
121. Sijben JWC, Calder PC. Differential immunomodulation with longchain n-3 PUFA in health and chronic disease. Proc Nutr Soc Lond 2007; 66: 237-59.
122. Geerling BJ, van Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer JM. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol 1999; 94: 410-7.
123. Miura S, Tsuzuki Y, Hokari R, Ishii H. Modulation of intestinal immune system by dietary fat intake: Relevance to Crohn's disease. J Gastroenterol Hepatol 1998; 13: 1183-90.
124. Calder PC, Zurier RB. Polyunsaturated fatty acids and rheumatoid arthritis. Curr Opin Clin Nutr Metab Care 2001; 4: 115-21.
125. Calder PC. n-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 2003; 38: 343-52.
126. Mattacks CA, Sadler D, Pond CM. The effects of dietary lipids on adrenergically stimulated lipolysis in perinodal adipose tissue following prolonged activation of a single lymph node. Brit J Nutr 2002; 87: 375-82.
127. Gassull MA, Fernández-Bañares F, Cabré E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002; 51: 164-8.
128. Ramakers JD, Mensink RP, Verstege MI, Velde AAT, Plat J. An arachidonic acid-enriched diet does not result in more colonic inflammation as compared with fish oil- or oleic acid-enriched diets in mice with experimental colitis. Brit J Nutr 2008; 100: 347-54.
129. Hyams J. Extra-intestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 1994; 19: 7-21.
130. Treem WR. Can Crohn's (at first) be only skin deep? J Pediatr Gastroenterol Nutr 1999; 28: 135-6.
131. Book DT, Smith TL, McNamar JP, Saeian K, Binion DG, Toohill RJ. Chronic sinonasal disease in patients with inflammatory bowel disease. Am J Rhinol 2003; 17: 87-90.
132. Schoon EJ, Geerling BG, Van Dooren IMA, et al. Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharmacol Ther 2001; 15: 783-92.
133. Stockbrügger RW, Schoon EJ, Bollani S, Sacco L, et al. Vertebral fractures: A frequent extra-intestinal manifestation in Crohn's disease. Gastroenterology 2001; 120: 3180.
134. Pond CM, Mattacks CA. Interactions between adipose tissue around lymph nodes and lymphoid cells in vitro. J Lipid Res 1995; 36: 2219-31.
135. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16: 1057-63.
136. Yudkin JS, Eringa E, Stehouwer CDA. "Vasocrine" signaling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365: 1817-20.
137. Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R. Perivascular adipose tissue as a messenger of the brain-vessel axis: Role in vascular inflammation and dysfunction. J Physiol Pharmacol 2007; 58: 591-610.
138. Reifenberger MS, Turk JR, Newcomer SC, Booth FW, Laughlin MH. Perivascular fat alters reactivity of coronary artery: Effects of diet and exercise. Med Sci Sports Exer 2007; 39: 2125-34.
139. Tanaka K, Sata M, Hirata Y, Nagai R. Perivascular adipose tissues anatomically communicate with atherosclerotic lesions via vasa vasorum; Possible link of adipo-vascular axis. Circulation 2006; 114: 23-.
140. Stern N, Marcus Y. Perivascular fat: innocent bystander or active player in vascular disease? J Cardiometab Syndr 2006; 1: 115-20.
141. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol 1989; 94B: 225-32.
142. Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 1990; 14: 1013-22.
143. Swifka J, Weiss J, Addicks K, Eckel J, Rosen P. Epicardial fat from guinea pig: A model to study the paracrine network of interactions between epicardial fat and myocardium? Cardiovasc Drugs Therapy 2008; 22: 107-14.
144. Iacobellis G, Pond CM, Sharma AM. Different "Weight" of cardiac and general adiposity in predicting left ventricle morphology. Obesity 2006; 14: 1679-84.
145. Iacobellis G, Sharma AM. Epicardial adipose tissue as new cardiometabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Design 2007; 13: 2180-4.
146. Iacobellis G, Barbaro G, Gerstein HC. Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol 2008; 128: 424-6.
147. Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity 2008; 16: 887-92.
148. Fain JN, Sacks HS, Buehrer B, et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obesity 2008; 32: 810-5.
149. Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 2008; 40: 442-5.
150. Chaowalit N, Lopez-Jimenez F. Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries? Europ Heart J 2008; 29: 695-7.
151. Pruchnic R, Katsiaras A, He J, Kelley DE, Winters C, Goodpaster BH. Exercise training increases intramyocellular lipid and oxidative capacity in older adults. Am J Physiol 2004; 287: E857-E62.
152. Goodpaster BH, Stenger VA, Boada F, et al. Skeletal muscle lipid concentration quantified by magnetic resonance imaging. Am J Clin Nutr 2004; 79: 748-54.
153. Gardan D, Gondret F, Louveau I. Lipid metabolism and secretory function of porcine intramuscular adipocytes compared with subcutaneous and perirenal adipocytes. Am J Physiol 2006; 291: E372-E80.
154. Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J ClinNutr 2007; 85: 377-84.
155. Manabe Y, Toda S, Miyazaki K, Sugihara H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 2003; 201: 221-8.
156. Motrescu ER, Rio MC. Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle. Biol Chem 2008; 389: 1037-41.
157. Yamaguchi J, Ohtani H, Nakamura K, Shimokawa I, Kanematsu T. Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast. Am J Clin Pathol 2008; 130: 382-8.
158. Celis JE, Moreira JMA, Cabezon T, et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients - Toward dissecting the molecular circuitry of epithelialadipocyte stromal cell interactions. Molec Cell Proteom 2005; 4: 492-522.
159. Núñez NP, Oh WJ, Rozenberg J, et al. Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res 2006; 66: 5469-76.
160. Irigaray P, Newby JA, Lacomme S, Belpomme D. Overweight/obesity and cancer genesis: More than a biological link. Biomed Pharmacother 2007; 61: 665-78.
161. Kampa M, Pelekanou V, Castanas E. Membrane-initiated steroid action in breast and prostate cancer. Steroids 2008; 73: 953-60.
162. Vázquez-Martín A, Colomer R, Brunet J, Lupu R, Menéndez JA. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif 2008; 41: 59-85.
163. Menéndez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-77.
164. Tripp RA, Topham DJ, Watson SR, Doherty PC. Bone marrow can function as a lymphoid organ during primary immune response under conditions of disrupted lymphocyte trafficking. J Immunol 1997; 158: 3716-20.
165. Rozman C, Feliu E, Rozman M, Reverter JC, Climent C, Berga L. Acquired aplastic anemia - a steriologic analysis of the bone marrow adipose tissue and its clinicial correlations. Medicina Clinica 1993; 101: 441-5.
166. Yokota T, Meka CSR, Medina KL, et al. Paracine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 2002; 109: 1303-10.
167. Yokota T, Meka CSR, Kouro T, et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 2003; 171: 5091-9.
168. Suzawa M, Takada I, Yanagisawa J, et al. Cytokines suppress adipogenesis and PPAR-function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 2003; 5: 224-30.
169. Maurin AC, Chavassieux PM, Vericel E, Meunier PJ. Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone 2002; 31: 260-6.
170. Compston JE. Bone marrow and bone: a functional unit. J Endocrinol 2002; 173: 387-94.
171. Justesen J, Mosekilde L, Holmes M, et al. Mice deficient in 11βhydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation. Endocrinology 2004; 145: 1916-25.
172. Kampmeier OF. Evolution and comparative morphology of the lymphatic system. 1969. Charles C. Thomas, Springfield Ill.
173. Farmer CG. Reproduction: The adaptive significance of endothermy. Am Nat 2003; 162: 826-40.
174. Geiser F. Evolution of daily torpor and hibernation in birds and mammals: Importance of body size. Clin Exp Pharmacol Physiol 1998; 25: 736-9.
175. Singer D. Phylogeny of mammalian metabolism. Anasthesiol Intensivmed NotfMed Schmerzther 2002; 37: 441-60.
176. Carey HV, Andrews MT, Martin SL. Mammalian hibernation: Cellular and molecular responses to depressed metabolism and low temperature. Physiol Rev 2003; 83: 1153-81.
177. Prendergast BJ, Freeman DA, Zucker I, Nelson RJ. Periodic arousal from hibernation is necessary for initiation of immune responses in ground squirrels. Am J Physiol 2002; 282: R1054-R62.